Plasminogen activator inhibitor-1 (PAI-1) stimulates human corneal epithelial cell adhesion and migration in vitro

Experimental Eye Research

Volumn 80, Issue 1, 2005, Pages 1-8

  Wang, Zhiyu ^a   Sosne, Gabriel ^a,b   Kurpakus Wheater, Michelle ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

adhesion; cornea; epithelium; human; migration; PAI 1

Indexed keywords

LAMININ; LAMININ 10; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL MIGRATION; CHEMOTAXIS; COLORIMETRY; CONTROLLED STUDY; CORNEA EPITHELIUM; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION; WESTERN BLOTTING; WOUND HEALING;

CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; CHEMOTAXIS; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; EYE PROTEINS; HUMANS; LAMININ; MICROSCOPY, FLUORESCENCE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERINE PROTEINASE INHIBITORS;

EID: 12344326746     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2004.06.006     Document Type: Article

References (45)

1. Al-Fakhri N., Chavakis T., Schmidt-Woll T., Huang B., Cherian S.M., Bobryshev Y.V., Lord R.S., Katz N., Preissner K.T. Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties. Biol. Chem. 384:2003;423-435
2. Andreasen P.A., Kjoller L., Christensen L., Duffy M.J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Can. 72:1997;1-22
3. Berk R.S., Katar M., Dong Z., Day D.E. Plasminogen activators and inhibitors in the corneas of mice infected with Pseudomonas aeruginosa. Invest. Ophthalmol. Vis. Sci. 42:2001;1561-1567
4. Chang H., Shyu K.G., Lin S., Wang B.W., Liu Y.C., Lee C.C. Cell adhesion induces the plasminogen activator inhibitor-1 gene expression through phosphatidylinositol 3-kinase/Akt activation in anchorage dependent cells. Cell Commun. Adhes. 9:2002;239-247
5. Chazaud B., Ricoux R., Christov C., Plonquet A., Gherardi R.K., Barlovatz-Meimon G. Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations. Am. J. Pathol. 160:2002;237-246
6. Degryse B., Sier C.F., Resnati M., Conese M., Blasi F. PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor. FEBS Lett. 505:2001;249-254
7. Dua H.S., Gomes J.A., Singh A. Corneal epithelial wound healing. Br. J. Ophthalmol. 78:1994;401-408
8. Esco M.A., Wang Z., McDermott M.L., Kurpakus-Wheater M. Potential role for laminin 5 in hypoxia-mediated apoptosis of human corneal epithelial cells. J. Cell Sci. 114:2001;4033-4040
9. Gipson I.K. Adhesive mechanisms of the corneal epithelium. Acta Ophthalmol. Suppl. 202:1992;13-17
10. Hjortland G.O., Bjornland K., Pettersen S., Garman-Vik S.S., Emilsen E., Nesland J.M., Fodstad O., Engebraaten O. Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1. Clin. Exp. Metast. 20:2003;301-309
11. Isogai C., Laug W.E., Shimada H., Declerck P.J., Stins M.F., Durden D.L., Erdreich-Epstein A., DeClerck Y.A. Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. Can. Res. 61:2001;5587-5594
12. Klatte D.H., Kurpakus M.A., Grelling K.A., Jones J.C. Immunochemical characterization of three components of the hemidesmosome and their expression in cultured epithelial cells. J. Cell Biol. 109:1989;3377-3390
13. Lahteenmaki K., Kuusela P., Korhonen T.K. Plasminogen activation in degradation and penetration of extracellular matrices and basement membranes by invasive bacteria. Methods. 21:2000;125-132
14. Lala P.K., Lee B.P., Xu G., Chakraborty C. Human placental trophoblast as an in vitro model for tumor progression. Can. J. Physiol. Pharmacol. 80:2002;142-149
15. Lawrence D.A., Palaniappan S., Stefansson S., Olson S.T., Francis-Chmura A.M., Shore J.D., Ginsburg D. Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis. J. Biol. Chem. 272:1997;7676-7680
16. Lin L., Kurpakus-Wheater M. Laminin α5 chain adhesion and signaling in conjunctival epithelial cells. Invest. Ophthalmol. Vis. Sci. 43:2002;2615-2621
17. Liu Y.X., Feng Q., Peng X.R., Tor N. Secretion of plasminogen activator inhibitor type 1 by cultured ovarian cells obtained from gonadotropin-treated immature rats. Sci. China B. 37:1994;940-947
18. Lu L., Reinach P.S., Kao W.W. Corneal epithelial wound healing. Exp. Biol. Med. (Maywood). 226:2001;653-664
19. Molinas C.R., Elkelani O., Campo R., Luttun A., Carmeliet P., Koninckx P.R. Role of the plasminogen system in basal adhesion formation and carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice. Fertil. Steril. 80:2003;184-192
20. Oyaizu H., Adachi Y., Taketani S., Tokunaga R., Fukuhara S., Ikehara S. A crucial role of caspase 3 and caspase 8 in paclitaxel-induced apoptosis. Mol. Cell Biol. Res. Commun. 2:1999;36-41
21. Palmieri D., Lee J.W., Juliano R.L., Church F.C. Plasminogen activator inhibitor-1 and -3 increase cell adhesion and motility of MDA-MB-435 breast cancer cells. J. Biol. Chem. 277:2002;40950-40957
22. Pepper M.S., Sappino A.P., Montesano R., Orci L., Vassalli J.D. Plasminogen activator inhibitor-1 is induced in migrating endothelial cells. J. Cell Physiol. 153:1992;129-139
23. Planus E., Barlovatz-Meimon G., Rogers R.A., Bonavaud S., Ingber D.E., Wang N. Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading. J. Cell Sci. 110:1997;1091-1098
24. Praus M., Collen D., Gerard R.D. Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis. Int. J. Cancer. 102:2002;584-591
25. Proia R.R., Nelson P.R., Mulligan-Kehoe M.J., Wagner R.J., Kehas A.J., Powell R.J. The effect of endothelial cell overexpression of plasminogen activator inhibitor-1 on smooth muscle cell migration. J. Vasc. Surg. 36:2002;164-171
26. Providence K.M., White L.A., Tang J., Gonclaves J., Staiano-Coico L., Higgins P.J. Epithelial monolayer wounding stimulates binding of USF-1 to an E-box motif in the plasminogen activator inhibitor type 1 gene. J. Cell Sci. 115:2002;3767-3777
27. Reidy M.A., Irvin C., Lindner V. Migration of arterial wall cells. Expression of plasminogen activators and inhibitors in injured rat arteries. Circ. Res. 78:1996;405-414
28. Reuning U., Magdolen V., Wilhelm O., Fischer K., Lutz V., Graeff H., Schmitt M. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review). Int. J. Oncol. 13:1998;893-906
29. Romer J., Lund L.R., Eriksen J., Ralfkiaer E., Zeheb R., Gelehrter T.D., Dano K., Kristensen P. Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. J. Invest. Dermatol. 97:1991;803-811
30. Seebacher T., Manske M., Zoller J., Crabb J., Bade E.G. The EGF-inducible protein EIP-1 of migrating normal and malignant rat liver epithelial cells is identical to plasminogen activator inhibitor 1 and is a component of the ECM migration tracks. Exp. Cell Res. 203:1992;504-507
31. Stefansson S., Lawrence D.A. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature. 383:1996;441-443
32. Stefansson S., Lawrence D.A. Old dogs and new tricks: proteases, inhibitors, and cell migration. Sci STKE. 189:2003;pe24
33. Stepanova V.V., Tkachuk V.A. Urokinase as a multidomain protein and polyfunctional cell regulator. Biochemistry (Mosc). 67:2002;109-118
34. Sumiyoshi K., Baba S., Sakaguchi S., Urano T., Takada Y., Takada A. Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis. Thromb. Res. 63:1991;59-71
35. Tervo T., Tervo K., van Setten G.B., Virtanen I., Tarkkanen A. Plasminogen activator and its inhibitor in the experimental corneal wound. Exp. Eye Res. 48:1989;445-449
36. Tishler R.B., Geard C.R., Hall E.J., Schiff P.B. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res. 52:1992;3495-3497
37. Umeda T., Eguchi Y., Okino K., Kodama M., Hattori T. Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues. J. Pathol. 183:1997;388-397
38. Varela J.C., Goldstein M.H., Baker H.V., Schultz G.S. Microarray analysis of gene expression patterns during healing of rat corneas after excimer laser photorefractive keratectomy. Invest. Ophthalmol. Vis. Sci. 43:2002;1772-1782
39. Vaughan D.E. PAI-1 and cellular migration: dabbling in paradox. Arterioscler. Thromb. Vasc. Biol. 22:2002;1522-1523
40. Waltz D.A., Natkin L.R., Fujita R.M., Wei Y., Chapman H.A. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J. Clin. Invest. 100:1997;58-67
41. Wang Z., Kurpakus-Wheater M. Decreased plasminogen activator inhibitor-1 secretion in hypoxic corneal epithelial cells is associated with increased urokinase plasminogen activator activity. Int. J. Biochem. Cell Biol. 35:2003;339-348
42. Watanabe M., Yano W., Kondo S., Hattori Y., Yamada N., Yanai R., Nishida T. Up-regulation of urokinase-type plasminogen activator in corneal epithelial cells induced by wounding. Invest. Ophthalmol. Vis. Sci. 44:2003;3332-3338
43. Wilson S.E., He Y.G., Weng J., Zieske J.D., Jester J.V., Schultz G.S. Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor, on proliferation, motility and differentiation of human corneal epithelial cells. Exp. Eye Res. 59:1994;665-678
44. Zagon I.S., Sassani J.W., McLaughlin P.J. Cellular dynamics of corneal wound reepithelialization in the rat II. DNA synthesis of the ocular surface epithelium following wounding. Brain Res. 839:1999;243-252
45. Zhang K., Kramer R.H. Laminin 5 deposition promotes keratinocyte motility. Exp. Cell Res. 227:1996;309-322